image
argenx SE ARGX
Healthcare - Biotechnology - NASDAQ - NL
Watchlist
$ 564.225
-5.18 %
$ 33.7 B
Market Cap
-732.76
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 198.56% 58.42% 40.94%
Annual Report FY 10-K 2022-12-31 -17.40% -73.81% -106.36%
Annual Report FY 10-K 2021-12-31 1009.97% 37.24% 32.13%
Annual Report FY 10-K 2020-12-31 -42.69% -256.37% -156.90%
Annual Report FY 10-K 2019-12-31 218.10% -139.47% -113.62%
Annual Report FY 10-K 2018-12-31 -43.75% -126.32% -240.32%
Annual Report FY 10-K 2017-12-31 182.33% -49.84% -22.15%
Annual Report FY 10-K 2016-12-31 106.49% -34.28% -32.02%
Annual Report FY 10-K 2015-12-31 64.07% -33.48% -30.60%
Annual Report FY 10-K 2014-12-31 23.56% -48.14% -51.85%
Annual Report FY 10-K 2013-12-31 69.30% 33.99% 35.28%
Annual Report FY 10-K 2012-12-31 49.75% -185.59% -181.75%
Annual Report FY 10-K 2011-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 73.82% 225.84% 117.60%
Quarterly Report Q2 8-K 2024-06-30 224.25% 65.58% -55.37%
Quarterly Report Q1 8-K 2024-03-31 82.99% -113.35% 9.95%
Quarterly Report Q4 8-K 2023-12-31 133.94% -157.21% -30.15%
Quarterly Report Q3 8-K 2023-09-30 139.01% 69.09% 61.37%
Quarterly Report Q2 8-K 2023-06-30 259.80% 54.79% 41.51%
Quarterly Report Q1 8-K 2023-03-31 836.02% 87.29% 53.42%
Quarterly Report Q4 8-K 2022-12-31 569.28% 83.76% 50.74%
Quarterly Report Q3 8-K 2022-09-30 16000.47% -0.61% 2.03%
Quarterly Report Q2 8-K 2022-06-30 -75.92% -201.50% -183.47%
Quarterly Report Q1 8-K 2022-03-31 -85.20% -461.89% -1713176.92%
Quarterly Report Q4 8-K 2021-12-31 800.04% -82.32% -89.49%
Quarterly Report Q3 8-K 2021-09-30 -92.53% -48.18% -109.12%
Quarterly Report Q2 8-K 2021-06-30 1682.31% 211.51% 226.51%
Quarterly Report Q1 8-K 2021-03-31 1711.21% -62.15% 99.97%
Quarterly Report Q4 8-K 2020-12-31 -43.43% 590.66% 567.90%
Quarterly Report Q3 8-K 2020-09-30 -71.98% -2080.17% -1401.06%
Quarterly Report Q4 8-K 2019-12-31 1132.20% -174.13% -94.36%
Quarterly Report Q3 8-K 2019-09-30 257.29% -30.37% -91.09%
Quarterly Report Q2 8-K 2019-06-30 -38.16% -3977.78% -362.93%
Quarterly Report Q1 8-K 2019-03-31 496.12% 134.82% 61.10%
Quarterly Report Q4 8-K 2018-12-31 -86.22% -136.22% -231.21%
Quarterly Report Q3 8-K 2018-09-30 -68.23% -92.03% -215.66%
Quarterly Report Q2 8-K 2018-06-30 -25.44% -272.59% -955.21%
Quarterly Report Q1 8-K 2018-03-31 -3.49% -142.21% -94.39%
Quarterly Report Q4 8-K 2017-12-31 180.52% -71.23% -38.75%
Quarterly Report Q3 8-K 2017-09-30 39.74% -68.32% -36.79%
Quarterly Report Q2 8-K 2017-06-30 391.10% 91.95% 125.93%
Quarterly Report Q1 8-K 2017-03-31 183.34% -167.00% -166.19%
Quarterly Report Q4 8-K 2016-12-31 94.67% -55.05% -52.15%
Quarterly Report Q3 8-K 2016-09-30 114.43% -70.83% -74.48%
Quarterly Report Q2 8-K 2016-06-30 118.88% -3.66% -3.77%
Quarterly Report Q1 8-K 2016-03-31 91.66% -4.34% 3.64%
Quarterly Report Q4 8-K 2015-12-31 6.07% -18.47% -18.52%
Quarterly Report Q3 8-K 2015-09-30 27.80% -98.46% -65.57%
Quarterly Report Q2 8-K 2015-06-30 459.50% -26.47% -24.07%
Quarterly Report Q1 8-K 2015-03-31 179.40% -25.97% -34.07%
Quarterly Report Q4 8-K 2014-12-31 90.59% -118.81% -121.31%
Quarterly Report Q3 8-K 2014-09-30 20.15% -1599.59% -2001.52%
Quarterly Report Q2 8-K 2014-06-30 -41.83% 7.21% 6.65%
Quarterly Report Q1 8-K 2014-03-31 -16.20% -10.42% -8.95%
Quarterly Report Q4 8-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2013-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2013-03-31 0.00% 0.00% 0.00%